Tetanus

Tetanus is a severe and often fatal neurological disease affecting all species of farm animals, caused by the potent neurotoxin produced by the bacterium Clostridium tetani. This anaerobic, spore-forming organism is ubiquitous in soil and the gastrointestinal tracts of herbivores, making exposure virtually unavoidable in agricultural settings. The disease develops when bacterial spores enter the body through wounds, germinate in anaerobic conditions, and produce tetanospasmin, one of the most potent biological toxins known. This toxin travels along nerve pathways to the central nervous system where it blocks inhibitory neurotransmitter release, resulting in the characteristic uncontrolled muscle rigidity and spasms that define clinical tetanus.

All farm animal species are susceptible to tetanus, though significant variation exists in species sensitivity and typical presentation patterns. Horses are exquisitely sensitive to tetanospasmin and develop severe clinical disease from very small amounts of toxin, making equine tetanus a true medical emergency with historically high mortality rates. Sheep and goats demonstrate intermediate sensitivity and are commonly affected following wounds from shearing, castration, tail docking, and other routine management procedures. Cattle display relative resistance compared to horses but can still develop fatal tetanus, particularly following surgical procedures or contaminated wounds. Pigs, llamas, alpacas, and poultry can all be affected though with varying frequency and severity.

The economic and welfare impact of tetanus in farm animal populations extends beyond direct mortality to encompass the costs of prevention, treatment, and management of affected animals. The intensely painful muscle spasms and progressive nature of the disease make tetanus a significant animal welfare concern, with affected animals experiencing severe distress even with appropriate treatment. Treatment costs for tetanus can be substantial, requiring intensive nursing care, antitoxin administration, antimicrobial therapy, and supportive care often extending over weeks. The high mortality rate even with treatment, ranging from thirty to eighty percent depending on species and severity, means that many treated animals are ultimately lost despite considerable investment.

Early detection and immediate veterinary intervention are critical factors in tetanus outcomes, as treatment initiated before significant toxin binding to neural tissue can dramatically improve survival rates. Once tetanospasmin binds to its targets in the nervous system, the effects are irreversible and recovery depends on regeneration of affected nerve terminals, a process requiring weeks. Understanding the risk factors for tetanus, recognizing early clinical signs, and maintaining effective vaccination programs are essential components of farm animal health management across all livestock operations.

The primary cause of tetanus in farm animals is infection with Clostridium tetani and subsequent production of tetanospasmin neurotoxin within wound sites. Clostridium tetani is a gram-positive, anaerobic, spore-forming bacterium found universally in soil, particularly in soil enriched with animal manure. The spores are remarkably resistant to environmental conditions including heat, desiccation, and many disinfectants, allowing them to persist in the environment for years. When spores enter wounds and encounter anaerobic conditions with low oxygen tension and appropriate nutrients, they germinate into vegetative bacterial cells capable of producing toxin. Deep puncture wounds, wounds with necrotic tissue, wounds contaminated with soil or feces, and surgical sites provide ideal conditions for spore germination and toxin production.

While tetanus is not a hereditary condition, individual animal factors can influence susceptibility and disease severity. Species differences in sensitivity to tetanospasmin represent innate variation, with horses being approximately one hundred times more sensitive than cattle to equivalent amounts of toxin. Immune status is the most significant individual factor, as animals with adequate circulating antitoxin antibodies from vaccination or passive transfer are protected against disease. Young animals may be protected by maternal antibodies for the first weeks to months of life depending on the dam's immune status and colostrum intake. Nutritional status and overall health influence immune function and wound healing, potentially affecting disease risk.

Environmental and management factors play crucial roles in tetanus epidemiology and represent the most modifiable risk elements for prevention. The density of Clostridium tetani spores in soil varies with soil type, moisture, temperature, and organic matter content, with heavily contaminated agricultural soils presenting higher risk. Management practices that create wounds provide entry points for infection, including castration, tail docking, ear tagging, dehorning, shearing, hoof trimming, and various surgical procedures. The method of performing these procedures affects risk, with rubber ring application for castration and tail docking associated with higher tetanus incidence than surgical methods due to the prolonged wound presence with necrotic tissue. Contamination of umbilical cords in neonates represents a significant route of infection.

Specific risk factors for tetanus development include wound characteristics, timing relative to vaccination, and environmental contamination levels. Deep puncture wounds that seal over quickly are particularly dangerous because the anaerobic conditions favoring bacterial growth are maintained. Wounds contaminated with soil, rust, or fecal material carry higher bacterial loads. Animals with inadequate vaccination history or waning immunity are at increased risk. Time of year may influence risk, with some evidence suggesting increased incidence during warmer months when bacterial proliferation is enhanced. Concurrent infections or tissue damage that compromise blood supply to wound areas increase anaerobic conditions favorable for clostridial growth.

The pathophysiology of tetanus involves toxin production at the wound site followed by systemic distribution primarily via neural pathways. Following germination of spores and bacterial multiplication in wounds, Clostridium tetani produces tetanospasmin, a zinc-dependent metalloprotease toxin. The toxin binds to peripheral nerve terminals and undergoes retrograde axonal transport to reach the central nervous system. Within the spinal cord and brainstem, tetanospasmin cleaves proteins essential for release of inhibitory neurotransmitters including glycine and gamma-aminobutyric acid. Loss of inhibitory input to motor neurons results in their uncontrolled activation, producing the characteristic muscle rigidity and spasms. Autonomic nervous system dysfunction can also occur, causing cardiovascular instability and other systemic effects in severe cases.

Early warning signs of tetanus in farm animals may be subtle and easily overlooked, making vigilant observation of at-risk animals essential for early detection. Initial symptoms often include a slight change in gait characterized by stiffness, mild difficulty chewing or swallowing, and a somewhat anxious facial expression. Animals may show reluctance to move, mild bloat in ruminants due to decreased eructation, and general stiffness that might initially be attributed to other causes such as musculoskeletal injury. The incubation period from wound contamination to first clinical signs typically ranges from three days to four weeks, though cases developing outside this range are reported. Shorter incubation periods generally correlate with more severe disease and poorer prognosis.

The classic symptoms of tetanus vary somewhat between species but share common features reflecting the neuromuscular pathophysiology. In horses, early signs include erect ears, flared nostrils, and prolapse of the third eyelid, with progression to the characteristic sawhorse stance with rigid extension of all four limbs, neck extension, and elevated tail head. In cattle, sheep, and goats, similar progression occurs though the species-specific clinical picture may differ in details. Affected ruminants typically show stiff gait, abducted ears, elevated tail, and progressive difficulty eating due to masseter muscle rigidity producing the classic lockjaw presentation. Pigs demonstrate opisthotonus, lateral recumbency with rigid limbs, and may vocalize during spasms.

Behavioral changes in animals developing tetanus reflect both the direct effects of neuromuscular dysfunction and secondary pain and distress. Affected animals often appear anxious, alert, and hypersensitive to stimuli, with exaggerated startle responses to sounds, touch, or visual stimuli triggering dramatic worsening of muscle rigidity and spasms. Animals may separate from herdmates and seek quiet, dark locations that minimize stimulation. Decreased feed and water intake results from difficulty approaching feed sources, inability to prehend and chew effectively, and the physical impossibility of lowering the head in animals with severe neck rigidity. Some animals may appear almost statue-like between spasm episodes, standing rigidly in place for extended periods.

Physical signs of tetanus progress in severity as toxin continues to bind in the central nervous system. Muscle rigidity typically begins locally near the wound site and spreads to become generalized, affecting all striated muscles including those of mastication, respiration, and locomotion. Trismus, or lockjaw, results from sustained contraction of masseter muscles and prevents normal mouth opening for feeding. The sardonic grin or risus sardonicus results from contraction of facial muscles. Difficulty swallowing leads to drooling of saliva. Respiratory compromise develops as intercostal and diaphragmatic muscles are affected, producing rapid shallow breathing and predisposing to aspiration pneumonia. Urinary retention and constipation result from affected sphincter muscles.

Symptom progression in tetanus follows a relatively predictable course with generalization of rigidity followed by increasingly severe tetanic spasms. Spasms may be spontaneous or triggered by external stimuli and appear as episodes of dramatically increased muscle contraction with opisthotonus, extension of limbs, and visible muscle fasciculations. Between spasms, animals remain rigid but may have some limited voluntary movement capability. As disease progresses, spasms become more frequent and prolonged, with shorter intervals between episodes. Death typically results from respiratory failure during prolonged spasm, aspiration pneumonia, or exhaustion and complications of recumbency.

Emergency symptoms requiring immediate veterinary intervention include respiratory distress with labored breathing and cyanosis, continuous spasm activity without periods of relaxation, recumbency with inability to rise, hyperthermia from sustained muscle activity, and signs of aspiration pneumonia such as coughing or nasal discharge. Animals found in lateral recumbency with rigid limbs and opisthotonus represent advanced cases with guarded prognosis even with aggressive treatment. Any animal showing signs consistent with tetanus following recent wounds or procedures warrants emergency evaluation, as early treatment before complete toxin binding offers the best chance for survival.

Clinical examination findings in tetanus are often sufficiently characteristic to allow diagnosis based on physical examination alone, making this primarily a clinical diagnosis in farm animal practice. The combination of generalized muscle rigidity, trismus, third eyelid prolapse, hypersensitivity to stimuli, and history of recent wounds or procedures creates a recognizable clinical syndrome. Neurological examination reveals increased muscle tone throughout the body, normal to exaggerated spinal reflexes, and intact sensory function. The animal's mentation is typically normal to mildly anxious, distinguishing tetanus from primary brain diseases that alter consciousness. Identification of a wound that could serve as the entry point for infection supports the diagnosis, though the inciting wound may have healed by the time clinical signs develop and is not always found.

Diagnostic testing for tetanus is of limited utility because the clinical presentation is usually diagnostic and definitive laboratory confirmation is difficult. Isolation of Clostridium tetani from wounds is possible using anaerobic culture techniques but is neither sensitive nor specific for clinical disease, as the organism may be present in wounds without causing disease or may be absent from wounds by the time clinical signs develop. Toxin detection assays exist in research settings but are not routinely available for clinical diagnosis. Blood work findings are nonspecific and may include muscle enzyme elevations from sustained muscle activity and stress leukogram. Analysis of cerebrospinal fluid is typically normal in tetanus, which can help differentiate from infectious meningitis or encephalitis.

Differential diagnosis for tetanus in farm animals must consider other conditions causing muscle rigidity, recumbency, or neurological abnormalities. Strychnine poisoning produces similar generalized muscle rigidity and spasms but typically has acute onset without the prodromal stiffness seen in tetanus and may be associated with known exposure to rodenticides. Hypocalcemia in cattle causes recumbency but is characterized by flaccid paralysis rather than rigidity and responds to calcium therapy. Hypomagnesemia produces hyperexcitability and muscle tremors that might be confused with early tetanus. Botulism causes flaccid paralysis that is the neuromuscular opposite of tetanus rigidity. Rabies must always be considered in unvaccinated animals with behavioral changes and neurological signs. Meningitis and other central nervous system infections typically cause altered mentation and additional neurological deficits beyond muscle rigidity.

Herd-level diagnostic considerations for tetanus focus on identifying common risk factors when multiple animals are affected within a short time period. Clustering of tetanus cases suggests a common source of wound contamination, inadequate vaccination coverage, or a management procedure being performed without appropriate prophylaxis. Investigation should examine recent procedures such as castration, tail docking, or shearing and assess whether appropriate tetanus prophylaxis was provided. Environmental sampling for Clostridium tetani is generally not useful given the ubiquitous nature of the organism, but assessment of soil conditions and manure management may identify particularly high-risk areas. Review of vaccination records determines whether adequate herd immunity exists and whether specific animal groups may have been missed in vaccination programs.

Emergency and immediate treatment of tetanus in farm animals aims to neutralize circulating toxin before it binds to neural tissue, eliminate the source of toxin production, and provide supportive care to maintain vital functions during recovery. Upon suspicion or diagnosis of tetanus, the highest priority is administration of tetanus antitoxin, which consists of antibodies capable of binding and neutralizing tetanospasmin. Antitoxin should be given as soon as possible because it can only neutralize toxin that has not yet bound to neurons; once toxin is bound, antitoxin cannot reverse its effects. The wound site should be identified if possible and treated with debridement, irrigation, and exposure to oxygen to create conditions unfavorable for continued bacterial growth and toxin production.

Medical management of tetanus combines antimicrobial therapy against Clostridium tetani with medications to manage muscle rigidity and spasms. Penicillin is the traditional antibiotic of choice as Clostridium tetani is uniformly sensitive, though metronidazole is increasingly favored because it penetrates necrotic tissue better and does not potentiate the effects of tetanospasmin as some studies suggest penicillin might. Muscle relaxant therapy is essential for managing rigidity and spasms, with options including acepromazine, diazepam, methocarbamol, and magnesium sulfate infusions. The goal is to reduce muscle tone enough to allow the animal to eat, drink, and breathe comfortably without producing excessive sedation. For food-producing animals, withdrawal times for all administered medications must be documented and observed if the animal survives and is destined for slaughter.

Surgical intervention in tetanus cases is limited to wound management when an active infection site can be identified. Wounds should be opened, debrided to remove necrotic tissue providing anaerobic environment for bacterial growth, thoroughly irrigated, and left open to air. Foreign bodies including rubber castration bands should be removed. Some clinicians advocate infiltration of the wound area with tetanus antitoxin in addition to systemic administration. In cases where the wound is extensive or involves critical structures, surgical consultation may be appropriate. Tracheostomy may be necessary in severe cases with laryngospasm or upper airway obstruction, though this is more commonly performed in horses than other farm animals.

Supportive care requirements for tetanus are intensive and largely determine whether animals survive the acute phase of disease. Affected animals should be housed in quiet, dark environments with minimal stimulation to reduce spasm-triggering stimuli. Deep bedding is essential for recumbent animals. Nutritional support must be provided, which may require stomach tubing in animals unable to eat voluntarily due to trismus. Intravenous fluid therapy maintains hydration and allows medication administration. Bladder care including catheterization may be necessary for urinary retention. Temperature regulation is important as muscle activity can cause hyperthermia while recumbency predisposes to hypothermia. Recumbent animals must be repositioned regularly to prevent pressure sores and dependent lung consolidation.

Herd treatment protocols for tetanus are not applicable in the typical sense since the disease is not contagious and does not spread between animals. However, when a tetanus case occurs, evaluation of herd vaccination status and prophylactic treatment of other animals that underwent the same procedure may be warranted. Animals recently subjected to the same management procedure such as castration or shearing should be examined for wounds and considered for prophylactic antitoxin and toxoid administration if their vaccination status is unknown or inadequate. This represents an excellent opportunity to review and strengthen the overall herd tetanus prevention program.

Treatment decisions for tetanus must balance the potential for recovery against animal welfare considerations, treatment costs, and practical limitations. Mild cases with localized stiffness and retained ability to eat and drink have reasonable prognosis with treatment. Moderate cases with generalized rigidity but maintained standing have guarded prognosis requiring intensive nursing care for extended periods. Severe cases with recumbency, continuous spasms, or respiratory compromise carry poor prognosis regardless of treatment intensity. The species affects prognosis, with horses generally having higher mortality than cattle. Economic factors including treatment costs potentially exceeding animal value, labor availability for intensive nursing care, and duration of expected recovery period all influence decisions. Euthanasia should be considered when prognosis is poor and continued treatment would prolong suffering without reasonable expectation of recovery.

Recovery timelines for tetanus in farm animals are prolonged because recovery requires regeneration of nerve terminals to restore normal neurotransmitter release, a process that cannot be accelerated with any known treatment. Animals surviving the acute phase of tetanus typically show initial improvement in spasm frequency and severity within one to two weeks of beginning treatment, but complete recovery may require four to six weeks or longer. The duration of clinical signs before treatment initiation correlates with recovery time, as more extensive toxin binding requires more nerve terminal regeneration. Even with successful recovery, some animals may retain mild residual stiffness or gait abnormalities for extended periods.

Post-treatment care and monitoring extend throughout the recovery period and require sustained commitment from caretakers. Animals should be maintained in quiet, low-stimulation environments until spasms have completely resolved. Nutritional support should continue until the animal can eat and drink normally without assistance. Gradual reintroduction of normal feeding as jaw function returns helps rebuild body condition lost during the acute illness. Physical therapy including passive range of motion exercises and encouraged walking as muscle function returns supports restoration of normal locomotion. Ongoing monitoring for secondary complications including aspiration pneumonia, pressure sores, and muscle atrophy allows early intervention. Regular reassessment of pain control ensures animal comfort throughout recovery.

Prognosis factors for tetanus recovery relate primarily to disease severity at presentation, time to treatment, and species affected. Animals presenting with mild localized disease and treated early have survival rates of seventy percent or better in some series. Those presenting with severe generalized disease, recumbency, or respiratory compromise have survival rates of twenty to forty percent even with aggressive treatment. Horses have traditionally had higher mortality rates than cattle, likely reflecting their increased sensitivity to tetanospasmin. Younger animals may have slightly better prognosis than older animals. Development of complications during treatment including aspiration pneumonia significantly worsens prognosis. Response to initial treatment provides prognostic information, with animals showing improvement within the first week having better outcomes than those with static or progressing disease.

Return to production considerations for tetanus survivors include full restoration of function and completion of medication withdrawal periods. Animals recovering from tetanus can return to full productive function once recovered, as there are no expected long-term sequelae from the disease itself in survivors. Breeding animals can return to reproduction following recovery. Dairy animals can return to milk production with appropriate withdrawal time observation for any medications administered. Meat animals must complete all withdrawal periods before slaughter. Documentation of treatment dates and withdrawal times ensures compliance with food safety requirements. Vaccination status should be updated following recovery, as clinical tetanus does not reliably produce protective immunity, and recovered animals remain susceptible to future disease without adequate immunization.

Vaccination protocols represent the cornerstone of tetanus prevention in farm animals and are highly effective when properly implemented. Tetanus toxoid vaccines stimulate active immunity by presenting inactivated tetanospasmin to the immune system, producing protective antibody responses that prevent disease following subsequent exposure. Primary vaccination requires two doses given three to six weeks apart to establish protective immunity, with annual boosters recommended to maintain protection. In horses, the high susceptibility makes vaccination particularly critical, and many protocols recommend boosting at the time of any significant injury or surgery. For other livestock species, ensuring adequate maternal immunity and providing appropriate vaccination at processing times protects young animals through high-risk periods.

Biosecurity measures for tetanus differ from those for contagious diseases since Clostridium tetani is ubiquitous in the environment rather than transmitted between animals. The focus instead is on reducing environmental contamination loads where practical and minimizing wound contamination when injuries or procedures occur. Maintaining clean bedding areas, appropriate manure management, and good drainage reduces the concentration of clostridial spores in areas where animals are housed and handled. Ensuring that surgical and processing areas are as clean as practical and that instruments are properly cleaned between animals reduces the risk of introducing heavily contaminated material into wounds.

Nutritional prevention relates to tetanus through maintaining adequate immune function and promoting optimal wound healing. Animals in good body condition with adequate protein, energy, vitamin, and mineral nutrition mount more robust vaccine responses and may clear wound infections more effectively. Adequate selenium and vitamin E status supports immune function. Ensuring adequate colostrum intake by neonates transfers maternal antibodies that protect young animals during the early weeks of life. Proper mineral supplementation supports tissue integrity and healing.

Management practices offer numerous opportunities to reduce tetanus risk through attention to wound prevention and prophylaxis at times of wound creation. All routine procedures that create wounds including castration, tail docking, ear tagging, dehorning, and shearing should be performed with clean instruments and attention to hygiene. Animals undergoing these procedures should have confirmed tetanus vaccination status or receive appropriate prophylaxis. Rubber ring application for castration and tail docking creates prolonged wounds that pose higher tetanus risk, and animals processed this way require particular attention to vaccination status. Surgical procedures should include tetanus prophylaxis as a standard protocol element.

Quarantine and testing protocols are not applicable to tetanus prevention in the traditional sense, but assessment of vaccination history for incoming animals and ensuring adequate immunization before mixing with the herd represents appropriate biosecurity practice. New arrivals should be vaccinated for tetanus if vaccination history is unknown or inadequate. Integrating tetanus vaccination into routine health protocols for new animals ensures protection before they undergo any procedures on the receiving farm. Testing for tetanus antibody titers is possible but rarely performed in routine practice, with vaccination being preferred over testing due to the high safety margin and low cost of tetanus immunization.

Daily management and monitoring of animals with tetanus requires consistent attention to their changing condition and intensive nursing care throughout the treatment period. Affected animals should be observed multiple times daily with assessments of respiratory rate and effort, frequency and severity of muscle spasms, ability to eat and drink, urination and defecation, and overall comfort level. Pain assessment is particularly important as tetanic spasms are extremely painful, and analgesic protocols should be adjusted based on observed animal responses. Medication administration schedules must be maintained precisely, with documentation of all treatments given. Environmental stimulation should be minimized through maintenance of quiet surroundings, with caretakers moving slowly and speaking softly when working with affected animals.

Housing and environmental management for tetanus cases prioritizes reduction of stimuli that trigger spasms while facilitating nursing care. The ideal environment is dark or dimly lit, quiet, and isolated from herd activity and farm operations. Stalls or pens should have adequate bedding to prevent injury during spasms, with walls and surfaces padded if the animal is experiencing severe episodes. Ambient temperature should be maintained in a comfortable range as affected animals cannot effectively thermoregulate through normal behavior. Water and feed should be accessible without requiring the animal to lower its head significantly if neck rigidity is present. For recumbent animals, positioning on deep bedding with ability to access the animal from all sides for repositioning is essential.

Herd health programs in the context of tetanus focus on maintaining population immunity through comprehensive vaccination protocols. All animals should receive primary tetanus vaccination series appropriate to their species, with regular boosters to maintain protection. Vaccination records should document which animals have been vaccinated, when, and with which products. Particular attention should be given to ensuring vaccination before any procedures that create wounds. Young animals should be vaccinated before processing procedures such as castration and tail docking. Pre-breeding vaccination of females ensures adequate maternal antibody transfer to offspring. Regular review of vaccination coverage identifies any animals or groups that may have been missed.

Record keeping and monitoring systems support both individual case management and population-level prevention programs. Individual animal records for tetanus cases should document presenting signs, treatments administered with dates and doses, response to treatment, and eventual outcome. For prevention programs, vaccination records should be maintained with sufficient detail to verify vaccination status of any individual animal. Records of tetanus cases over time allow identification of patterns that might suggest prevention program failures or particular risk factors on the operation. Drug inventory records ensure adequate antitoxin and other emergency supplies are maintained on farm.

Economic considerations for tetanus prevention and treatment heavily favor prevention through vaccination. Tetanus toxoid vaccines are inexpensive, costing minimal amounts per dose, while treatment of clinical tetanus cases requires antitoxin that costs considerably more, antimicrobials, muscle relaxants, and intensive nursing care that may extend over weeks. Treatment costs can easily exceed several hundred dollars for small animals and more for large animals, often exceeding the animal's market value. Labor costs for nursing care represent an additional significant expense. In contrast, maintaining comprehensive herd vaccination provides protection at a cost of a few dollars per animal per year. Even considering occasional prophylactic antitoxin administration at times of unplanned wounds, prevention is vastly more economical than treatment.

Species sensitivity differences rather than breed-specific risk characterize tetanus epidemiology in farm animals. Horses are the most sensitive domestic species, developing severe clinical disease from amounts of tetanospasmin that would not affect cattle. This exquisite sensitivity makes tetanus vaccination essential in all horses regardless of breed, with no evidence that particular breeds are more or less susceptible. Sheep and goats demonstrate intermediate sensitivity and experience significant mortality from tetanus, with management practices in these species creating frequent wound opportunities during shearing and other routine procedures. Cattle are relatively resistant compared to horses but remain susceptible, particularly following surgical procedures or contaminated wounds. Pigs, llamas, alpacas, and poultry are all susceptible with varying frequency of clinical cases.

Production type considerations influence tetanus risk primarily through the management practices associated with different production systems. Dairy cattle may face different wound opportunities than beef cattle, with foot problems and teat injuries being more common in dairy settings. Wool sheep undergo shearing that creates potential entry points for infection, while meat breeds may be processed at young ages with castration and tail docking wounds. Breeding animals of both sexes may sustain wounds during mating activities. Young animals undergoing multiple processing procedures in a short time face cumulative wound risk. Feedlot animals with minimal handling after arrival may have lower wound incidence than extensively managed animals but also may have less veterinary oversight for prompt wound treatment.

Genetic selection and testing for tetanus susceptibility are not applicable as the variation in susceptibility is at the species rather than individual or breed level. Selection emphasis should instead focus on overall health and vigor, as animals in good condition with robust immune systems respond better to vaccination and may clear wound infections more effectively. Culling decisions based on tetanus occurrence are not warranted since the disease reflects environmental exposure and vaccination status rather than individual genetic susceptibility. Breeding program focus should be on ensuring adequate vaccination of all breeding stock and their offspring rather than attempting to select for disease resistance.

Commonly co-occurring conditions with tetanus relate primarily to complications developing during the course of disease and intensive treatment. Aspiration pneumonia develops when affected animals cannot swallow normally and inhale saliva, feed material, or regurgitated rumen contents. Pressure sores and decubital ulcers occur in recumbent animals that cannot reposition themselves adequately despite nursing care. Dehydration and malnutrition result from the animal's inability to eat and drink normally due to trismus and muscle rigidity. Constipation and urinary retention develop from sphincter involvement. Hyperthermia from sustained muscle activity or hypothermia from recumbency without adequate environmental control may occur. Muscle damage from severe sustained contraction can lead to myoglobinuria.

Conditions with similar clinical presentations to tetanus must be differentiated to ensure appropriate treatment. Strychnine poisoning produces generalized rigidity and spasms similar to tetanus but has acute onset without prodromal stiffness and may be associated with rodenticide exposure. Hypocalcemia and hypomagnesemia cause recumbency and muscle abnormalities but with different clinical patterns. Botulism produces flaccid paralysis that is neurophysiologically opposite to tetanus rigidity. Meningitis and encephalitis may cause neurological abnormalities but typically include altered mentation not seen in tetanus. Rabies should always be considered in unvaccinated animals with neurological signs. Organophosphate toxicity can cause muscle fasciculations but also produces parasympathetic signs not seen in tetanus.

Complications and sequelae of tetanus extend beyond survival of the acute illness to potential long-term effects. Respiratory failure from sustained respiratory muscle spasm is the most common cause of death. Aspiration pneumonia may develop during the acute phase or during recovery as the animal regains ability to eat but not yet swallow normally. Muscle damage from prolonged severe contraction may result in persistent weakness or fibrosis affecting gait. Fractures can occur during violent spasms, particularly in horses and in animals cast on hard surfaces. Cardiac arrhythmias from autonomic dysfunction have been reported in severe cases. Animals surviving severe tetanus may experience prolonged rehabilitation periods with gradual return to normal function.